News

DUBLIN, Nov 22, 2021 (GLOBE NEWSWIRE) — By Type (Feeding Tube (Gastrostomy, Jejunostomy), Feeding Pump, Donation Kit), Age Group (Adult, Pediatric), Application (Diabetes) , Neurology), “Enteral Feeding Devices Market”, Disease, Cancer), End User (Hospitals, ACS, Home Care) – Global Forecast to 2026″ report has been added to ResearchAndMarkets.com’s offering.
The global enteral feeding devices market is expected to reach USD 4.9 billion in 2026 from USD 3.5 billion in 2021, growing at a CAGR of 6.6% during the forecast period.
Enteral feeding devices have become increasingly important in the healthcare industry over the years because of their various advantages over traditional nutrition management methods such as parenteral nutrition.In addition to being costly, parenteral nutrition has been associated with complications such as infection.Therefore, the global demand for advanced enteral feeding equipment is growing.
Factors such as rising healthcare costs; surge in preterm births; growth in aging populations; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal and neurological disorders; increased awareness of enteral nutrition; Rapid improvement will further drive the market over the forecast period.In addition, the shift from parenteral to enteral nutrition and increasing adoption and demand for enteral feeding devices in home and ambulatory care settings are also expected to drive the market over the next few years.
However, patient safety risks; increasing cases of feeding and medication errors; and complications associated with enteral feeding tubes, such as misconnection, tube displacement, and infection, are restraining the growth of this market to some extent.In addition, insufficient or lack of reimbursement in some developing and less developed countries, and global shortage of trained physicians, endoscopists, and nurses pose significant challenges to the growth of this market.
Based on product, the enteral feeding tube segment will hold the largest share during the forecast period
On the basis of type, the enteral nutrition devices market is segmented into enteral feeding tubes, drug delivery devices, enteral syringes, enteral nutrition pumps, and consumables.In 2020, the enteral feeding tube segment accounted for the largest share of the enteral feeding devices market, followed by drug delivery devices.The switch from parental feeding to enteral nutrition and the rise in cancer cases are expected to increase the adoption of enteral nutrition devices, which, in turn, will increase the global demand for management devices.
Oncology accounted for the largest share of the enteral nutrition devices market in 2020, followed by gastrointestinal disorders, neurological disorders, diabetes, hypermetabolism (9.2%), and other applications.Oncology will continue to dominate the market through 2026.The increased prevalence of various cancers, especially head and neck, gastrointestinal, lung, and liver cancers, is expected to play a major role.The adoption rate of enteral nutrition devices used to provide clinical nutrition to cancer patients is higher.
On the basis of age group, the enteral feeding devices market is segmented into adult patients (18 years and older) and pediatric patients (neonatal under 1 month, infants 1 month to 2 years, children 2 to 12 years, and adolescents 12 years and 16 years old).In 2020, the adult patient market share is larger.This can be attributed to the increasing incidence of chronic diseases and diseases that lead to malnutrition and the rapid increase in the elderly population.
Hospitals, home care facilities, and ambulatory care facilities are the major end users of the enteral feeding devices market.The hospital segment held the largest market share in 2020.The development of technologically advanced enteral nutrition devices and the shift from parenteral nutrition to enteral nutrition are supporting the growth of the hospital segment.
Asia Pacific is expected to be the fastest growing regional market for enteral feeding devices during the forecast period.Factors such as increasing number of preterm births, increasing geriatric population, increasing awareness of enteral nutrition, and rapid development of healthcare facilities in several Asia-Pacific countries are driving the growth of this market.Major players have shifted their focus to emerging economies in these regions and focused on expansion and acquisitions to gain greater market share in the coming years.
The report analyzes the enteral feeding devices market and aims to estimate the market size and future growth potential of this market based on various segments such as product type, age group, application, end user, and region.The report also includes a product portfolio matrix of various enteral feeding products in the market.The report also provides a competitive analysis of the key players in this market along with their company profiles, product offerings, and key market strategies.
AT&T Inc. (NYSE: T) may have been in a relative bear market since 2017.The company suffered two major blows, including a decline in March 2020 and WarnerMedia’s spin-off from Discovery, Inc (NASDAQ: DISC.A).Most retail shareholders are invested in AT&T due to its high historical dividend yield of 8.7% to 4.6% over the past decade.We will now assess how attractive AT&T is to investors going forward.
Yahoo Finance’s Ines Ferre reported that Uber shares rose, boosting the ride-sharing company with travel during the pandemic.
New Citi customers apply for designated Citibank credit cards through MoneyHero!The first shot of the new year, the exclusive reward of the upgraded version has Apple AirPods 3rd generation!No gift cards can be redeemed, they will be sent directly to you!
Tech stocks continued their gains today, with the Nasdaq Composite up about 1.9% as of 2:40 p.m. ET.Shares of Upstart Holdings (NASDAQ:UPST), a lender powered by artificial intelligence (AI), rose nearly 11% today, and shares of Brazilian fintech Nu Holdings (NYSE:NU) rose nearly 13%, Shares of Brazilian payments company StoneCo (NASDAQ: STNE) rose nearly 13% and were more than 5% higher.As has been discussed many times now, the market turned ugly from early November as the Fed took more seriously the rise in inflation caused by daily price increases.
Shares of Nvidia (NASDAQ: NVDA) rose sharply on Wednesday, rising as much as 5.5%.According to Barron’s, Nvidia stock was affected by some bullish comments from Rhys Williams, chief investment officer at Spouting Rock Asset Management.After shares fell as much as 34% from their November highs, Williams sees the sell-off as overdone and that Nvidia stock is a worthwhile buy, especially given the massive opportunity presented by the Metaverse.While Nvidia continues to generate most of its revenue from graphics processing units (GPUs) used in video games, the company’s data center segment has been growing at a faster rate.
As 2022 kicks off, we see a big drop in markets – but the real story is an increase in volatility.Especially in early February, when the market declines leveled off, daily trading was characterized by violent up and down swings.This situation places a burden on investors to recognize the right time to buy for the best profits.The key is not to try to “clock” in day-to-day trading, but to look at long-term trends and future predictors.Where to look for stock indicators’
Welcome rewards of up to HK$800 cash coupons and 1,020,000 points (equivalent to HK$3,400 or 68,000 miles) can be redeemed at will!
Heather Morgan and Ilya Lichtenstein arrested for laundering bitcoin stolen from Bitfinex in 2016
Stocks have been wildly volatile, but long-term investors were once again rewarded for patience on Wednesday as the major indexes continued to recover lost ground.The bond market, working with lower interest rates, helped establish the dominance of the stock market as an engine of financial growth.The Nasdaq Composite (NASDAQINDEX: ^IXIC) was again the best performer among the major averages, but the Dow Jones Industrial Average (DJINDICES: ^DJI) and S&P 500 (SNPINDEX: ^GSPC) were not far behind.
Yahoo Finance’s Rick Newman joins the livestream to discuss President Biden’s economic transcript.
Suntory’s unique fish oil “DHA & EPA + Sesame E” 4 capsules a day can drive away cardiovascular crisis, restore liver vitality, make sleep deeper, and get rid of urban risk factors!10% off for a limited time, don’t miss it!
Biden finally mentioned Tesla publicly, but that didn’t end the standoff between the president and visionary CEO Elon Musk.
Stock splits usually work, and a 20-for-1 split of Google parent Alphabet could spark a wave.
Shares of the Chinese electric vehicle (EV) maker were up more than 5% as of 2:55 p.m. ET.Barclays analyst Shao Jiong on Tuesday gave NIO shares an overweight rating.Shao noted that China is one of the world’s largest and most lucrative auto markets, in part because of the Chinese government’s support for its nascent electric vehicle industry.
Shares of uranium company Cameco Corporation (NYSE: CCJ) rose 14.8% in Wednesday’s trading after reporting its 2021 financial results.Shares closed the day just a penny below their trading high.
Download our User Experience Optimization Guide for tips, tricks, and valuable insights for optimizing user experience.
Disney (DIS) reported fourth-quarter fiscal 2021 results after the market closed on Wednesday, with the entertainment giant’s streaming service Disney+’s subscriber growth and a pickup in theme park traffic the metrics investors were most closely watching.
The volatility of the past few months has thrown stocks of many newly listed and highly valued companies into disarray.It’s not uncommon to see stocks drop 60% in 3 months.The fintech sector has been hit especially hard.Just look at the performance of SoFi Technologies (SOFI), which is down about 45% over the past 3 months.Investigating the situation, Oppenheimer’s Dominic Gabriel expects volatility to continue, although analysts see SoFi as having an “edge”
Market makers focused on disappointing bottom-line numbers in this earnings report and guidance update, shrugging off strong sales.Is that a bug?
Now enroll in Bowtie Voluntary Health Insurance Flexible Plan, purchase Gleneagles Hong Kong Hospital’s medical health package for +$200 per month, and enjoy 240+ designated medical packages “Full Indemnity”, and you can also enjoy an annual comprehensive physical examination (valued up to $2,700)!
After asking the FDA to authorize its Covid vaccine for emergency use, is Novavax stock a buy or a sell?Is NVAX stock a buy or a sell?
Shares of Doximity (NYSE: DOCS) rose 24% on Wednesday after the medical professionals networking platform announced strong third-quarter growth metrics.In the third quarter of fiscal 2022, which ended on Dec. 31, Doximity’s revenue rose 67% year over year to $97.9 million.Pharmaceutical companies and other healthcare providers are increasing their ad spending on the Doximity Network.
Small-cap companies listed in China often see their share prices fluctuate because of news events, even if the companies have no affiliation with news figures.
Beijing Kelly med Co.,Ltd , is one of the leading manufacture for feeding pumps in China since 1994 , Welcome to inquiry by whats app: 0086 17610880189 or E-mail: kellysales086@kelly-med.com